PRECLINICAL MECHANISTIC INVESTIGATION OF THE FIRST-IN-CLASS SIK2/SIK3 INHIBITOR GLPG3970 IN AN EXPERIMENTAL MODEL OF IBD

Stéphanie Lavazais  ¹     Adrien Cosson     Didier Merciris     Carole Delachaume     Laetitia Perret     Anne Gigout     Nicolas Desroy     David AMANTINI     Steve De Vos  ^2    
1 Galapagos SASU, Romainville, France
² Galapagos NV, Mechelen, Belgium

Topic
Disease Mechanisms, IBD, Immunology

Session
Basic science in IBD

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)